ACWM
BIIB icon

Adams Chetwood Wealth Management’s Biogen BIIB Stock Holding History

Adams Chetwood Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,060
Closed -$300K – 75
2021
Q3 		$300K Sell
1,060
-27
-2% -$8.85K 0.22% 67
2021
Q2 		$376K Sell
1,087
-40
-4% -$12.1K 0.27% 64
2021
Q1 		$315K Buy
1,127
+75
+7% +$20.2K 0.24% 66
2020
Q4 		$258K Hold
1,052
– – 0.21% 69
2020
Q3 		$298K Buy
1,052
+80
+8% +$22.3K 0.29% 60
2020
Q2 		$260K Hold
972
– – 0.26% 64
2020
Q1 		$305K Hold
972
– – 0.36% 54
2019
Q4 		$288K Buy
+972
New +$270K 0.29% 59

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Adams Chetwood Wealth Management's BIIB Position: Q4 2021 in Review

Adams Chetwood Wealth Management sold out of Biogen (BIIB) in Q4 2021, closing a stake of 1,060 shares — an estimated $300K sold.

Adams Chetwood Wealth Management first reported a position in BIIB in Q4 2019 and held it in 8 quarters. The position peaked at $376K in Q2 2021. 1,009 funds tracked by Wall St. Rank hold BIIB as of Q4 2021.

  • Adams Chetwood Wealth Management reported no remaining Biogen position as of Q4 2021 after selling out during the quarter.
  • Adams Chetwood Wealth Management sold 1,060 Biogen shares in Q4 2021, an estimated $300K.
  • Adams Chetwood Wealth Management first reported a position in Biogen in Q4 2019 and held it in 8 quarters.
  • Adams Chetwood Wealth Management's Biogen position peaked at $376K in Q2 2021.
  • 1,009 funds tracked by Wall St. Rank held Biogen as of Q4 2021.

Based on Adams Chetwood Wealth Management's 13F filing for Q4 2021, filed 11 Feb 2022.